Costs caused by bleeds within the therapy of acute coronary syndromes in Germany;Durch blutungen verursachte kosten bei der therapie des akuten koronarsyndroms in Deutschland

Herz

Volumn 34, Issue 6, 2009, Pages 479-484

  Bufe, Alexander ^a   Frey, Simon ^b   Briswalter, Stéphanie ^b  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b GLAXOSMITHKLINE   (Germany)

Author keywords

Acute coronary syndrome (ACS); Antithrombotics; Bleeds; Costs; NSTEMI; Resource use; STEMI

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEMOGLOBIN;

ACUTE CORONARY SYNDROME; ARTICLE; BLOOD; BRAIN HEMORRHAGE; GASTROINTESTINAL HEMORRHAGE; GERMANY; HEALTH CARE COST; HEMOGLOBIN BLOOD LEVEL; HOSPITAL; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PUNCTURE; RETROPERITONEAL HEMORRHAGE; RETROSPECTIVE STUDY;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANTICOAGULANTS; COMORBIDITY; FEMALE; GERMANY; HEALTH CARE COSTS; HEMORRHAGE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 70349668646     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-009-3189-6     Document Type: Article

References (13)

1. Antithrombotic Trialists' Collaboration. 2002 Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 71 86 10.1136/bmj.324. 7329.71
2. J.P. Bassand C.W. Hamm D. Ardissino 2007 Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes Eur Heart J 28 1598 660 17569677 10.1093/eurheartj/ehm132 1:CAS:528:DC%2BD2sXpslKmtLw%3D (Pubitemid 47355992)
3. Deutsche Krankenhausgesellschaft, Hrsg. DKG-NT Bd I. Tarif der Deutschen Krankenhausgesellschaft für die Abrechnung erbrachter Leistungen und für die Kostenerstattung vom Arzt an das Krankenhaus, 31. Aufl. Stuttgart: Kohlhammer, 2007.
4. J.W. Eikelboom S.S. Anand K. Malmberg 2000 Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis Lancet 355 1936 42 10859038 10.1016/S0140-6736(00)02324-2 1:CAS:528:DC%2BD3cXks1Srsbs%3D
5. J.J. Ferguson R.M. Califf E.M. Antman 2004 Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial JAMA 292 45 54 15238590 10.1001/jama.292.1.45 1:CAS:528:DC%2BD2cXls1elsrg%3D (Pubitemid 38923793)
6. InEK (Institut für das Entgeltsystem im Krankenhaus). G-DRG V2007/2009 HA-Report-Browser ( http://www.g-drg.de/cms/index.php/inek-site-de/ content/view/full/1943, Stand 06.05.2009).
7. M. Moscucci K.A. Fox C.P. Cannon 2003 Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 1815 23 14563340 10.1016/S0195-668X(03)00485-8 1:STN:280:DC%2BD3svosFemsw%3D%3D (Pubitemid 37280247)
8. OASIS-2 Study Investigators. 1999 Effects of recombinant hirudin compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial Lancet 353 429 38 10.1016/S0140-6736(98)07332- 2 (Pubitemid 29067333)
9. PRISM-PLUS Study Investigators. 1998 Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators N Engl J Med 338 1488 97 10.1056/NEJM199805213382102 (Pubitemid 28226276)
10. The PRISM Study Investigators. 1998 A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators N Engl J Med 338 1498 505 10.1056/NEJM199805213382103 (Pubitemid 28226277)
11. PURSUIT Trial Investigators. 1998 Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy N Engl J Med 339 436 43 10.1056/NEJM199808133390704 (Pubitemid 28377685)
12. S. Yusuf S.R. Mehta S. Chrolavicius 2006 Comparison of fondaparinux and enoxaparin in acute coronary syndromes N Engl J Med 354 1464 76 16537663 10.1056/NEJMoa055443 1:CAS:528:DC%2BD28XjtFWhuro%3D
13. S. Yusuf F. Zhao S.R. Mehta 2001 Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 494 502 11519503 10.1056/NEJMoa010746 1:CAS:528: DC%2BD3MXms1arsrY%3D (Pubitemid 32758501)